CV Sciences, Inc.: CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids

CV Sciences (OTCQB:CVSI) launched PlusHLTH.com, a direct-to-consumer site for its +PlusHLTH non-cannabinoid product line, expanding beyond its PlusCBDOil.com focus on hemp-derived CBD. The company says the site supports its “Health Intelligence” approach with science-backed education and plans to add new formulations and delivery formats.

Original reporting
Published Aug 12, 2026, 3:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 3:09 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CVSI
Bullish
medium confidence
Mentioned
$CVSI
Relevance
4/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$CVSIBullishLow
01

Why it matters

The company is creating a dedicated DTC destination for +PlusHLTH while keeping PlusCBDOil.com focused on hemp-derived CBD, signaling continued brand expansion beyond cannabinoids.

02

Market read

This is a brand and channel expansion update. It may support sentiment around the company’s diversification strategy, but it lacks quantified financial impact.

03

What to watch

Traders may want to watch for follow-on disclosures such as new product SKUs, marketing spend changes, or any updates to distribution and compliance for non-cannabinoid supplements.

Relevance 4/10Novelty 4/10Timing: today’s PR, immediately following the PlusHLTH.com launch announcement

Background

CV Sciences is a consumer wellness company with the +PlusCBD brand and a newer +PlusHLTH line aimed at healthy aging and everyday health.

Company-level read

Ticker impact

$CVSIBullishMedium confidence
Context

CV Sciences announced the launch of PlusHLTH.com as the primary digital home for its +PlusHLTH non-cannabinoid product line.

Expected impact

Near-term impact likely limited to sentiment, with follow-through depending on subsequent sales/traffic metrics.

Evidence & confidence

The article is a product/marketing platform launch with qualitative strategy language, not guidance, funding, or regulatory developments.

Market effects

Highlights ongoing consumer-health DTC investment and brand segmentation beyond CBD, which may be a modest read-through for small hemp-adjacent peers.

No specific regional market linkage beyond the company’s San Diego base.

Primarily US-focused DTC branding; no international regulatory or distribution changes mentioned.

Counterpoint

Without disclosed traction metrics, the launch could be more promotional than revenue-driving, limiting any sustained stock reaction.

Key entities

  • CV Sciences, Inc.

    OTCQB-listed consumer health company launching PlusHLTH.com as the DTC hub for its +PlusHLTH line.

  • PlusHLTH.com

    New direct-to-consumer website dedicated exclusively to the +PlusHLTH product line and education content.

  • +PlusHLTH

    Non-cannabinoid nutritional product line including dietary supplements and Empowr plant-based protein with creatine.

Related articles

$AALMed

American Airlines Management Shake-up Aims To Close Leverage With Competitors and Improve Service

American Airlines began a senior leadership reorganization, according to an Aug. 10 letter from CEO Robert Isom. Several executives are resigning or retiring, while roles expand for communications and customer service. The changes aim to improve operations and returns and close a profit gap versus Delta and United. In Q2 2026, American reported $71M net income versus $805M at United and $1.6B at Delta.

$RIOMed

Federal politics live: $2.5bn Tomago bailout 'vital' to protect Australia's largest aluminium smelter, minister says

Australia’s federal and NSW governments will announce a $2.5 billion, 10-year bailout for Tomago Aluminium, aimed at securing power supply and decarbonisation. Industry Minister Tim Ayres said the deal includes profit sharing with the Commonwealth when aluminium prices are high and $100 million for decarbonisation and demand-response. Separately, Labor will introduce a revised News Bargaining Incentive bill requiring big tech to make at least eight content deals.

$LMTMedAI 8/10

Lockheed Martin wins $211 million UAE defense contract

Lockheed Martin (NYSE:LMT) said the U.S. Missile Defense Agency awarded a $211.4 million contract modification to manufacture THAAD missile defense launchers for the United Arab Emirates. The change raises the 2019 contract total to $1.05 billion, with production from Aug 2026 to Jan 2031 under Foreign Military Sales funding.

$INTCMed

5 Things to Know Before the Stock Market Opens on Tuesday

Stock futures edged higher after Monday’s decline as investors awaited AI-related earnings. Oil prices wavered after hopes for an Iran deal faded. Intel (INTC) raised its stock offering to $20B, pricing about 210.53M shares at $95. Riot Platforms (RIOT) jumped after results and a $9.1B, 20-year Anthropic compute deal. Several AI-linked earnings were scheduled.

$STEMMed

Stem, Inc.: Stem's PowerTrack EMS Enables Hybridization of Two Operating Utility-Scale Solar Plants in Hungary

Stem, Inc. (NYSE: STEM) said Solarmarkt Group, with EPC partner Pannonwatt, selected Stem’s PowerTrack Energy Management System to hybridize two operating utility-scale solar plants in Hungary. The five-year agreement covers adding 40 MW/80 MWh batteries to each site, targeting commercial operation by Sept 2026 and participation in Hungary’s aFRR market.

$DNNMedAI 8/10

Denison Reports Financial and Operational Results for Q2 2026, Highlighted by Significant Initial Progress from Construction Activities at the Phoenix In-Situ Recovery ('ISR') Uranium Mine

Denison Mines (TSX:DML, NYSE American:DNN) filed Q2 2026 financial results and MD&A. It said Phoenix ISR site preparation began in March 2026, with over 20% of site civil work completed by end-July and key concrete and freeze-wall milestones on track. In Q2, it sold 750,000 lb U3O8 at $122.16/lb, generating $91.6m proceeds and a $64.1m, 233% gain.